Real-world Experience with Sofosbuvir-based Regimens for Chronic Hepatitis C, Including Patients with Factors Previously Associated with Inferior Treatment Response

The introduction of sofosbuvir, a direct acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). Phase 3 clinical trials have demonstrated the efficacy, simplicity, and tolerability of sofosbuvir-based regimens and report high rates of sustained virological response (S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hawaii J Med Public Health
Main Authors: Wu, Christina J, Roytman, Marina M, Hong, Leena K, Huddleston, Leslie, Trujillo, Ruby, Cheung, Alvin, Poerzgen, Peter, Tsai, Naoky CS
Formato: Artigo
Idioma:Inglês
Publicado em: University Clinical, Education & Research Associate (UCERA) 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582387/
https://ncbi.nlm.nih.gov/pubmed/26793407
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados